Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

67
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
67
Viral Meningitis01:18

Viral Meningitis

151
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
151
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

60
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
60
Influenza01:27

Influenza

52
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
52
Viral Recombination00:57

Viral Recombination

25.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.9K
Viral Mutations00:36

Viral Mutations

41.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
41.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An observational diagnostic accuracy study comparing the urine dipstick with a consensus-based reference standard for the diagnosis of urinary tract infections in older adults.

BMC geriatrics·2026
Same author

Does early letermovir initiation delay engraftment?

Antimicrobial agents and chemotherapy·2026
Same author

Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Swiss community-based surveillance of respiratory virus co-occurrence in 2022-2024.

Microbiology spectrum·2026
Same author

Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.

Antimicrobial agents and chemotherapy·2026
Same author

[Bilateral infectious cellulitis of the lower limbs : does it exist ?]

Revue medicale suisse·2026

Related Experiment Video

Updated: Apr 15, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.8K

[Infections disease update: 2014 is viral].

Laurent Kaiser, Stéphane Emonet, Angela Huttner

    Revue Medicale Suisse
    |March 25, 2015
    PubMed
    Summary

    Chikungunya virus and Ebola virus require immediate attention for returning travelers. Emerging infectious diseases necessitate updated clinical guidelines for conditions like gonorrhea and pneumonia.

    More Related Videos

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    31.0K
    Detection of Infectious Virus from Field-collected Mosquitoes by Vero Cell Culture Assay
    07:23

    Detection of Infectious Virus from Field-collected Mosquitoes by Vero Cell Culture Assay

    Published on: June 9, 2011

    19.1K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.8K
    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
    09:29

    Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

    Published on: October 29, 2015

    31.0K
    Detection of Infectious Virus from Field-collected Mosquitoes by Vero Cell Culture Assay
    07:23

    Detection of Infectious Virus from Field-collected Mosquitoes by Vero Cell Culture Assay

    Published on: June 9, 2011

    19.1K

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Oncology

    Context:

    • Global dissemination of Chikungunya virus and Ebola virus necessitates heightened clinical suspicion in returning travelers.
    • The human microbiome's role in colorectal cancer screening and urinary tract infections (UTIs) warrants further investigation.
    • Evolving antimicrobial resistance patterns are reshaping treatment strategies for common infections like gonorrhea and severe community-acquired pneumonias.

    Purpose:

    • To provide concise updates on the management and clinical relevance of various infectious diseases and oncological conditions.
    • To highlight emerging pathogens and changing epidemiological landscapes impacting public health.
    • To emphasize the need for evidence-based therapeutic approaches in light of evolving resistance and disease characteristics.

    Summary:

    • Chikungunya and Ebola virus require vigilance in travelers returning from endemic regions.
    • Microbiome analysis shows potential in colorectal cancer screening and predicting UTIs from E. coli.
    • Updated management strategies are crucial for gonorrhea due to resistance, while bitherapy may benefit severe pneumonias.
    • Hepatitis C treatment focuses on patient selection, and Pritelivir shows promise for genital herpes.

    Impact:

    • Informing clinicians on current challenges in infectious disease diagnosis and management.
    • Guiding public health strategies for emerging infectious threats.
    • Promoting rational use of antimicrobial therapies and optimizing patient treatment pathways.